Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest & Investment Income (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Interest & Investment Income for 16 consecutive years, with $55000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income rose 83.33% year-over-year to $55000.0, compared with a TTM value of $219000.0 through Sep 2025, up 108.57%, and an annual FY2024 reading of $92000.0, down 56.4% over the prior year.
  • Interest & Investment Income was $55000.0 for Q3 2025 at Rockwell Medical, down from $69000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $69000.0 in Q2 2025 and bottomed at -$6000.0 in Q3 2022.
  • Average Interest & Investment Income over 5 years is $34562.5, with a median of $36000.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income crashed 93.57% in 2021, then soared 1033.33% in 2023.
  • Year by year, Interest & Investment Income stood at $5000.0 in 2021, then soared by 760.0% to $43000.0 in 2022, then decreased by 2.33% to $42000.0 in 2023, then plummeted by 30.95% to $29000.0 in 2024, then soared by 89.66% to $55000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for RMTI at $55000.0 in Q3 2025, $69000.0 in Q2 2025, and $66000.0 in Q1 2025.